Cyclophosphamide-associated hepatotoxicity.

Autores
Categoría Estudio primario
RevistaSouthern medical journal
Año 1985
Cyclophosphamide, a potent alkylating agent, is effective therapy for some rheumatic diseases. Despite primary hepatic activation of the drug, hepatic toxicity has been reported only in one case. We have reported two episodes of hepatic dysfunction associated with oral cyclophosphamide administration in patients with systemic rheumatic diseases.
Epistemonikos ID: 7ace354d0ea15ad6030e43eb729feeb0682b22c7
First added on: Oct 01, 2013